Smith Group Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Smith Group Asset Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$680K	Buy	7,085 +100	+1%	+$10.3K	0.03%	131
2026 Q1	$763K	Buy	6,985 +2,851	+69%	+$272K	0.04%	105
2025 Q4	$335K	Buy	4,134 +178	+4%	+$15.3K	0.02%	157
2025 Q3	$346K	Buy	3,956 +161	+4%	+$14.4K	0.02%	154
2025 Q2	$315K	Sell	3,795 -2,461	-39%	-$206K	0.02%	157
2025 Q1	$525K	Buy	6,256 +24	+0.4%	+$2.23K	0.04%	132
2024 Q4	$574K	Buy	6,232 +63	+1%	+$6.06K	0.04%	132
2024 Q3	$573K	Buy	+6,169	New	+$535K	0.05%	96
2017 Q4	–	Sell	-17,310	Closed	-$648K	–	456
2017 Q3	$648K	Sell	17,310 -100	-0.6%	-$3.4K	0.02%	196
2017 Q2	$544K	Buy	+17,410	New	+$503K	0.02%	206

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Smith Group Asset Management's LMAT Position: Q2 2026 in Review

Smith Group Asset Management increased its LeMaitre Vascular (LMAT) stake by 1.4% in Q2 2026, buying an estimated $10.3K and bringing the position to 7,085 shares worth $680K. The position accounts for 0.03% of the portfolio, ranked #131.

Smith Group Asset Management first reported a position in LMAT in Q2 2017 and has held it in 10 quarters since. The position peaked at $763K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Smith Group Asset Management held 7,085 shares of LeMaitre Vascular worth $680K as of Q2 2026.
Smith Group Asset Management bought 100 LeMaitre Vascular shares in Q2 2026, an estimated $10.3K.
LeMaitre Vascular made up 0.03% of Smith Group Asset Management's portfolio in Q2 2026, its #131 holding.
Smith Group Asset Management first reported a position in LeMaitre Vascular in Q2 2017 and has held it in 10 quarters since.
Smith Group Asset Management's LeMaitre Vascular position peaked at $763K in Q1 2026.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Smith Group Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.